Ivan Mičetić

Ivan Mičetić

Auto-generated profile, based on publicly available information

Ivan Mičetić

Universita degli Studi di Padova Dipartimento di Scienze Biomediche, Padova, I-35131

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DPDamiano Piovesan
Damiano Piovesan
FTFrancesco Tabaro
Francesco Tabaro
IMIvan Mičetić
Ivan Mičetić
MNMarco Necci
Marco Necci
FQFederica Quaglia
Federica Quaglia
STSilvio Tosatto
Silvio Tosatto
The Database of Protein Disorder (DisProt, URL: www.disprot.org) has been significantly updated and upgraded since its last major renewal in 2007. The current release holds information on more than 800 entries of IDPs/IDRs, i.e. intrinsically disordered proteins or regions that exist and function without a well-defined three-dimensional structure. We have re-curated previous entries to purge DisProt from conflicting cases, and also upgraded the functional classification scheme to reflect continuous advance in the field in the past 10 years or so. We define IDPs as proteins that are disordered along their entire sequence, i.e. entirely lack structural elements, and IDRs as regions that are at least five consecutive residues without well-defined structure. We base our assessment of disorder strictly on experimental evidence, such as X-ray crystallography and nuclear magnetic resonance (primary techniques) and a broad range of other experimental approaches (secondary techniques). Confident and ambiguous annotations are highlighted separately. DisProt 7.0 presents classified knowledge regarding the experimental characterization and functional annotations of IDPs/IDRs, and is intended to provide an invaluable resource for the research community for a better understanding structural disorder and for developing better computational tools for studying disordered proteins.

25 November 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DPDamiano Piovesan
Damiano Piovesan
MNMarco Necci
Marco Necci
NENahuel Escobedo
Nahuel Escobedo
AMAlexander Monzon
Alexander Monzon
AHAndrás Hatos
András Hatos
STSilvio Tosatto
Silvio Tosatto
The MobiDB database (URL: https://mobidb.org/) provides predictions and annotations for intrinsically disordered proteins. Here, we report recent developments implemented in MobiDB version 4, regarding the database format, with novel types of annotations and an improved update process. The new website includes a re-designed user interface, a more effective search engine and advanced API for programmatic access. The new database schema gives more flexibility for the users, as well as simplifying the maintenance and updates. In addition, the new entry page provides more visualisation tools including customizable feature viewer and graphs of the residue contact maps. MobiDB v4 annotates the binding modes of disordered proteins, whether they undergo disorder-to-order transitions or remain disordered in the bound state. In addition, disordered regions undergoing liquid-liquid phase separation or post-translational modifications are defined. The integrated information is presented in a simplified interface, which enables faster searches and allows large customized datasets to be downloaded in TSV, Fasta or JSON formats. An alternative advanced interface allows users to drill deeper into features of interest. A new statistics page provides information at database and proteome levels. The new MobiDB version presents state-of-the-art knowledge on disordered proteins and improves data accessibility for both computational and experimental users.

10 November 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DPDamiano Piovesan
Damiano Piovesan
FTFrancesco Tabaro
Francesco Tabaro
LPLisanna Paladin
Lisanna Paladin
MNMarco Necci
Marco Necci
IMIvan Mičetić
Ivan Mičetić
STSilvio Tosatto
Silvio Tosatto
The MobiDB (URL: mobidb.bio.unipd.it) database of protein disorder and mobility annotations has been significantly updated and upgraded since its last major renewal in 2014. Several curated datasets for intrinsic disorder and folding upon binding have been integrated from specialized databases. The indirect evidence has also been expanded to better capture information available in the PDB, such as high temperature residues in X-ray structures and overall conformational diversity. Novel nuclear magnetic resonance chemical shift data provides an additional experimental information layer on conformational dynamics. Predictions have been expanded to provide new types of annotation on backbone rigidity, secondary structure preference and disordered binding regions. MobiDB 3.0 contains information for the complete UniProt protein set and synchronization has been improved by covering all UniParc sequences. An advanced search function allows the creation of a wide array of custom-made datasets for download and further analysis. A large amount of information and cross-links to more specialized databases are intended to make MobiDB the central resource for the scientific community working on protein intrinsic disorder and mobility.

3 November 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JIJon Ison
Jon Ison
KRKristoffer Rapacki
Kristoffer Rapacki
HMHervé Ménager
Hervé Ménager
MKMatúš Kalaš
Matúš Kalaš
EREmil Rydza
Emil Rydza
SBSøren Brunak
Søren Brunak
Life sciences are yielding huge data sets that underpin scientific discoveries fundamental to improvement in human health, agriculture and the environment. In support of these discoveries, a plethora of databases and tools are deployed, in technically complex and diverse implementations, across a spectrum of scientific disciplines. The corpus of documentation of these resources is fragmented across the Web, with much redundancy, and has lacked a common standard of information. The outcome is that scientists must often struggle to find, understand, compare and use the best resources for the task at hand. Here we present a community-driven curation effort, supported by ELIXIR—the European infrastructure for biological information—that aspires to a comprehensive and consistent registry of information about bioinformatics resources. The sustainable upkeep of this Tools and Data Services Registry is assured by a curation effort driven by and tailored to local needs, and shared amongst a network of engaged partners. As of November 2015, the registry includes 1785 resources, with depositions from 126 individual registrations including 52 institutional providers and 74 individuals. With community support, the registry can become a standard for dissemination of information about bioinformatics resources: we welcome everyone to join us in this common endeavour. The registry is freely available at https://bio.tools.

29 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LCLaura Civiero
Laura Civiero
RVRenée Vancraenenbroeck
Renée Vancraenenbroeck
Elisa BelluzziElisa Belluzzi
Elisa Belluzzi
ABAlexandra Beilina
Alexandra Beilina
ELEvy Lobbestael
Evy Lobbestael
JTJean-Marc Taymans
Jean-Marc Taymans
Leucine-rich repeat kinase 1 and 2 (LRRK1 and LRRK2) are large multidomain proteins containing kinase, GTPase and multiple protein-protein interaction domains, but only mutations in LRRK2 are linked to familial Parkinson's disease (PD). Independent studies suggest that LRRK2 exists in the cell as a complex compatible with the size of a dimer. However, whether this complex is truly a homodimer or a heterologous complex formed by monomeric LRRK2 with other proteins has not been definitively proven due to the limitations in obtaining highly pure proteins suitable for structural characterization. Here, we used stable expression of LRRK1 and LRRK2 in HEK293T cell lines to produce recombinant LRRK1 and LRRK2 proteins of greater than 90% purity. Both purified LRRKs are folded, with a predominantly alpha-helical secondary structure and are capable of binding GTP with similar affinity. Furthermore, recombinant LRRK2 exhibits robust autophosphorylation activity, phosphorylation of model peptides in vitro and ATP binding. In contrast, LRRK1 does not display significant autophosphorylation activity and fails to phosphorylate LRRK2 model substrates, although it does bind ATP. Using these biochemically validated proteins, we show that LRRK1 and LRRK2 are capable of forming homodimers as shown by single-particle transmission electron microscopy and immunogold labeling. These LRRK dimers display an elongated conformation with a mean particle size of 145 Å and 175 Å respectively, which is disrupted by addition of 6M guanidinium chloride. Immunogold staining revealed double-labeled particles also in the pathological LRRK2 mutant G2019S and artificial mutants disrupting GTPase and kinase activities, suggesting that point mutations do not hinder the dimeric conformation. Overall, our findings indicate for the first time that purified and active LRRK1 and LRRK2 can form dimers in their full-length conformation.

1 January 2016 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
Giovanni LibralatoGiovanni Libralato
Giovanni Libralato
ADA. Costa Devoti
A. Costa Devoti
MZM. Zanella
M. Zanella
ESE. Sabbioni
E. Sabbioni
IMI. Mičetić
I. Mičetić
AGA. Volpi Ghirardini
A. Volpi Ghirardini